| Item Type | Name |
|
Academic Article
|
Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
|
|
Academic Article
|
The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.
|
|
Academic Article
|
The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
|
|
Academic Article
|
Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase.
|
|
Academic Article
|
Association of apolipoprotein A phenotypes and oxidized low-density lipoprotein immune complexes in children.
|
|
Academic Article
|
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
|
|
Academic Article
|
Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages.
|
|
Academic Article
|
Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of FC gamma receptor II (FcgammaRII).
|
|
Academic Article
|
Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.
|
|
Academic Article
|
Immunosuppressive effects of fish oil in normal human volunteers: correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes.
|
|
Academic Article
|
Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.
|
|
Academic Article
|
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.
|
|
Academic Article
|
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
|
|
Academic Article
|
Development of capture assays for different modifications of human low-density lipoprotein.
|
|
Academic Article
|
The immunogenicity of modified lipoproteins.
|
|
Academic Article
|
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.
|
|
Academic Article
|
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
|
|
Academic Article
|
Atherogenesis and the humoral immune response to modified lipoproteins.
|
|
Academic Article
|
Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation.
|
|
Academic Article
|
Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages.
|
|
Academic Article
|
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.
|
|
Academic Article
|
Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress.
|
|
Academic Article
|
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
|
|
Academic Article
|
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
|
|
Academic Article
|
Humoral immunity and atherosclerosis.
|
|
Academic Article
|
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.
|
|
Academic Article
|
Immune mechanisms in the pathogenesis of atherosclerosis.
|
|
Academic Article
|
Immunological and microbiological factors in the pathogenesis of atherosclerosis.
|
|
Academic Article
|
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
|
|
Academic Article
|
Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.
|
|
Academic Article
|
Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.
|
|
Academic Article
|
Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes.
|
|
Academic Article
|
Role of simvastatin as an immunomodulator in type 2 diabetes.
|
|
Academic Article
|
Immune mechanisms of atherosclerosis in diabetes mellitus.
|
|
Academic Article
|
Lipoprotein-immune complexes and diabetic vascular complications.
|
|
Academic Article
|
Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages.
|
|
Academic Article
|
Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells.
|
|
Academic Article
|
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.
|
|
Academic Article
|
Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
|
|
Academic Article
|
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.
|
|
Academic Article
|
Clinical significance of the humoral immune response to modified LDL.
|
|
Academic Article
|
Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
|
|
Academic Article
|
Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.
|
|
Academic Article
|
Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice.
|
|
Academic Article
|
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
|
|
Academic Article
|
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.
|
|
Academic Article
|
Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
|
|
Academic Article
|
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes.
|
|
Academic Article
|
Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.
|
|
Concept
|
Antigens
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Antigen-Antibody Complex
|
|
Concept
|
Lymphocyte Antigen 96
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
CD36 Antigens
|
|
Academic Article
|
MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-? and high glucose in mononuclear cells?-?a potential role of MD-2 in Toll-like receptor 4-independent signalling.
|
|
Academic Article
|
Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis.
|
|
Academic Article
|
Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.
|
|
Academic Article
|
High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
|
|
Academic Article
|
CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate.
|
|
Academic Article
|
Immune complexes containing malondialdehyde (MDA) LDL induce apoptosis in human macrophages.
|
|
Academic Article
|
Immune Complexes and the Risk of CVD in Type 1 Diabetes.
|
|
Academic Article
|
GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice.
|
|
Academic Article
|
Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
|